MONUDIN

Welcome to the Brand page for “MONUDIN”, which is offered here for Gene therapy and prophylaxis products, gene transfer, regulation, modulation and delivery products for the treatment of motor neurone disease, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders;chemical and biochemical products for use in gene delivery technology, enzymes, proteins, growth factors and chemicals for in-vitro use in laboratories and for analysis in gene delivery technology; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology;instruments and apparatus for the administration of gene and antibody-based therapy and prophylaxis preparations and substances, pre-filled vials, syringes and injectors for medical purposes, all for the treatment of single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularization;scientific and medical research and development; genetic engineering services, biotechnology services, research and development of new technology for others in the field of biotechnology; licensing of intellectual property; product development consultation relating to gene therapy products; consultation services in the fields of medical and scientific research in the field of professional gene therapy;.

Its status is currently believed to be active. Its class is unavailable. “MONUDIN” is believed to be currently owned by “Oxford BioMedica plc”.

Owner:
OXFORD BIOMEDICA PLC
Owner Details
Description:
Gene therapy and prophylaxis products, gene transfer, regulation, modulation and delivery products for the treatment of motor neurone disease, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders;Chemical and biochemical products for use in gene delivery technology, enzymes, proteins, growth factors and chemicals for in-vitro use in laboratories and for analysis in gene delivery technology; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology;Instruments and apparatus for the administration of gene and antibody-based therapy and prophylaxis preparations and substances, pre-filled vials, syringes and injectors for medical purposes, all for the treatment of single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularization;Scientific and medical research and development; genetic engineering services, biotechnology services, research and development of new technology for others in the field of biotechnology; licensing of intellectual property; product development consultation relating to gene therapy products; consultation services in the fields of medical and scientific research in the field of professional gene therapy;
Categories: GENE THERAPY PROPHYLAXIS PRODUCTS